The New York Times – Business:
The vaccine maker said the U.S. regulator rejected its request to seek approval for a new product using mRNA technology, which Health Secretary Robert F. Kennedy Jr. has sharply criticized.
This post first appeared in The New York Times – Business. Read the original article.